HOLLY ALMOND: Open Payments
NPI 1649233503 · CORVALLIS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,985 in 54 payments from 26 companies in 2025. Trend: 2023 $658 · 2024 $1,259 · 2025 $1,985
Food & beverage: $1,985
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $334 |
| Janssen Scientific Affairs, LLC | 4 | $251 |
| ABBVIE INC. | 5 | $157 |
| Janssen Biotech, Inc. | 3 | $139 |
| Amgen Inc. | 1 | $125 |
| Tempus AI, Inc | 1 | $123 |
| PFIZER INC. | 4 | $122 |
| E.R. Squibb & Sons, L.L.C. | 4 | $96 |
| Gilead Sciences, Inc. | 4 | $85 |
| Adaptive Biotechnologies Corporation | 1 | $69 |
Products named: DARZALEX, EPKINLY, DATROWAY, IMDELLTRA (AMG757), XT CDX, RYBREVANT, OPDIVO, LYNPARZA.
Industry payments across OR — which companies pay providers there.
